---
title: "Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295190953.md"
description: "In Tokyo, Japan and Cambridge, UK, on 7 August 2026, Nxera Pharma, identified as \"the Company\" or \"Nxera\" with the stock symbol TSE: 4565, has issued an update on its operational endeavors and disclosed the consolidated outcomes for the second quarter concluding on 30 June 2026. Further details and the complete report are accessible via the provided link."
datetime: "2026-08-07T06:32:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295190953.md)
  - [en](https://longbridge.com/en/news/295190953.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295190953.md)
generator: "portal-rs"
---

# Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter 2026

In Tokyo, Japan and Cambridge, UK, on 7 August 2026, Nxera Pharma, identified as "the Company" or "Nxera" with the stock symbol TSE: 4565, has issued an update on its operational endeavors and disclosed the consolidated outcomes for the second quarter concluding on 30 June 2026. Further details and the complete report are accessible via the provided link.

### Related Stocks

- [4565.JP](https://longbridge.com/en/quote/4565.JP.md)

## Related News & Research

- [Nxera Pharma to receive USD 8.6 million milestone payment from Centessa](https://longbridge.com/en/news/297870158.md)
- [Nxera partner gains acceptance for NBI‑1117567](https://longbridge.com/en/news/298021570.md)
- [Igua Sergipe board signs off Q2 2026 financial results](https://longbridge.com/en/news/297932404.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)
- [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**